Erythromycin-induced immune hemolytic anemia
S J Nance1, S Ladisch, T L Williamson
1American Red Cross Blood Services, Los Angeles-Orange Counties Region, Calif.
Abstract:
A 3-year-old female receiving Pediazole (erythromycin ethylsuccinate and sulfisoxazole) for tonsillitis and otitis media developed severe hemolytic anemia. No serum drug-dependent antibodies could be demonstrated with an in vitro 'immune-complex' method using Pediazole, pure erythromycin ethylsuccinate or pure sulfisoxazole. However, a method using red cells coated with erythromycin base showed in vitro lysis of the erythromycin-coated red cells. This is only the second case of immune hemolytic anemia associated with erythromycin and the first where in vitro drug-dependent hemolysis was demonstrable.
Related Concept Videos
Allergic Drug Reactions
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Hypersensitivity Reactions: Cytolytic Reactions
Rocky Mountain Spotted Fever
Amebiasis
Hypersensitivity Reactions: Immune-Complex Reactions


